Clinical disability progression and platelet GP IIb/IIIa values in patients with atopic myelitis

Gulibahaer Ainiding, Ken Ichiro Yamashita, Takako Torii, Konosuke Furuta, Noriko Isobe, Takuya Matsushita, Katsuhisa Masaki, Shoji Matsumoto, Jun Ichi Kira

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Abstract

We aimed to clarify the disability progression and platelet aggregative function in atopic myelitis (AM). Seventeen AM patients and 35 healthy controls were subjected to clinico-allergological evaluations and glycoprotein IIb/IIIa (GP IIb/IIIa) measurements using a VerifyNow assay system. In AM patients, the disease duration had significant positive correlations with the Kurtzke Expanded Disability Status Scale scores and Sensory Functional Scale scores. The GP IIb/IIIa values were significantly higher in AM patients than in controls as well as in females compared with males. AM is essentially a progressive disease affecting the sensory system, and involves an increased platelet aggregative function.

Original languageEnglish
Pages (from-to)108-112
Number of pages5
JournalJournal of Neuroimmunology
Volume246
Issue number1-2
DOIs
Publication statusPublished - May 15 2012

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Clinical disability progression and platelet GP IIb/IIIa values in patients with atopic myelitis'. Together they form a unique fingerprint.

Cite this